Monofer (Ferric Derisomaltose)

Ferric Derisomaltose, the active ingredient in Monofer, is an iron supplement presented as a solution for injection for intravenous use. It treats iron deficiency anemia and related conditions such as chronic kidney disease‑related anemia and preoperative anemia in adult patients.

GNH USA supplies Monofer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Monofer is an intravenous iron preparation used to correct iron deficiency in several clinical settings.

- Iron deficiency anemia: restores hemoglobin levels and replenishes depleted iron stores. - Chronic kidney disease‑related anemia: provides readily available iron to support erythropoiesis in patients with renal impairment. - Preoperative anemia: raises hemoglobin concentrations before surgery to reduce peri‑operative transfusion requirements.

Monofer may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient feeling of sickness after infusion. - Headache: mild to moderate intensity. - Dizziness: often resolves shortly after administration. - Injection site reactions: redness, swelling, or pain at the infusion site. - Transient hypotension: brief drop in blood pressure during infusion. - Metallic taste: temporary alteration in taste perception.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypotension: prolonged low blood pressure post‑infusion. - Acute respiratory distress: difficulty breathing or wheezing. - Iron overload: excessive iron accumulation in organs. - Elevated liver enzymes: potential liver function abnormalities. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before using Monofer, consider the following safety measures.

- Renal impairment: monitor iron parameters and renal function closely. - History of hypersensitivity: avoid if the patient has previously reacted to ferric derisomaltose. - Cardiovascular disease: observe blood pressure during and after infusion. - Pregnancy and lactation: use only when the potential benefit justifies the potential risk. - Concurrent oral iron therapy: may interfere with infusion; consider timing adjustments. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Monofer can interact with other medicines; awareness helps prevent complications.

Major Interactions (Avoid): - Concurrent intravenous iron agents (e.g., iron dextran): risk of iron overload. - Simultaneous use with erythropoiesis‑stimulating agents: may exacerbate iron excess.

Moderate Interactions (Monitor Closely): - Oral phosphate binders: may reduce iron availability if taken close to infusion. - Antacids: could affect iron release when administered near the infusion time. - Chelating agents (e.g., deferoxamine): may bind released iron and diminish efficacy.